Smith Hunter C bought RYTM

August 12, 2025 · Form 4 insider transaction

Smith Hunter C bought 24,611 shares of Rhythm Pharmaceuticals, Inc. at $6.88 per share, a transaction worth $169.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.